Venetoclax plus dose-adjusted R-EPOCH (VR-DA-EPOCH) or G-EPOCH bridging to subsequent cellular therapy for the patients with transformed lymphoma a single center clinical experience
Sign Up to like & getrecommendations! Published in 2024 at "Annals of Hematology"
DOI: 10.1007/s00277-024-05618-x
Abstract: Indolent lymphoma, including chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) and follicular lymphoma (FL), can undergo histological transformation into an aggressive subtype, typically diffuse large B-cell lymphoma (DLBCL). The prognosis of transformed lymphoma is poor. In… read more here.
Keywords: epoch epoch; therapy; transformed lymphoma; epoch ... See more keywords
Contemporary trends in adverse neonatal outcomes: 138
Sign Up to like & getrecommendations! Published in 2019 at "American Journal of Obstetrics and Gynecology"
DOI: 10.1016/j.ajog.2018.11.159
Abstract: 138 Contemporary trends in adverse neonatal outcomes Courtney-Lynn V. Stahl, Robert M. Rossi, Emily A. DeFranco Department of Obstetrics and Gynecology, University of Cincinnati College of Medicine, Cincinnati, OH OBJECTIVE: ACOG published guidelines in 2013… read more here.
Keywords: death; contemporary trends; adverse neonatal; neonatal outcomes ... See more keywords
The Case for the Anthropocene Epoch Is Stronger Than the Case for the Holocene Epoch
Sign Up to like & getrecommendations! Published in 2025 at "Earth's Future"
DOI: 10.1029/2024ef005719
Abstract: The recommendation that the Anthropocene be denoted as a geological epoch was recently rejected by the International Union of Geological Sciences. Here, we compare the scientific rationales presented for the Anthropocene, the Holocene and the… read more here.
Keywords: holocene; stronger case; epoch; case anthropocene ... See more keywords
Successful Use of EPOCH-R in 2 Young Adult Patients With Burkitt Lymphoma and Acute Kidney Injury: A Case Report
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Pediatric Hematology/Oncology"
DOI: 10.1097/mph.0000000000001287
Abstract: Pediatric Burkitt lymphoma has historically been treated with intensive methotrexate-based chemotherapy, which improves patient survival while causing severe toxicities. Young patients typically have better outcomes with intensive therapies, while adults and immunocompromised patients have higher… read more here.
Keywords: successful use; use epoch; epoch young; burkitt lymphoma ... See more keywords
Trends in burden of atrial fibrillation over three decades: a population-based study
Sign Up to like & getrecommendations! Published in 2025 at "Heart"
DOI: 10.1136/heartjnl-2025-326510
Abstract: Background Atrial fibrillation (AF) is a common sustained cardiac arrhythmia with increasing prevalence and incidence worldwide. However, long-term trends in AF prevalence, incidence, associated risk factors, and the role of comorbidities, including sex-specific differences is… read more here.
Keywords: epoch; sex; population; population based ... See more keywords
Clinical and Cost Comparison Evaluation of Inpatient Versus Outpatient Administration of EPOCH-Containing Regimens in Non-Hodgkin Lymphoma
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Pharmacy Practice"
DOI: 10.1177/0897190016659210
Abstract: Background: Etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin (EPOCH)-containing regimens are frequently utilized in non-Hodgkin’s lymphoma, however, the incidence of febrile neutropenia (FN) in patients receiving inpatient versus outpatient EPOCH has not been described. Additionally, no comparisons… read more here.
Keywords: administration; containing regimens; cost; non hodgkin ... See more keywords
Dose-Adjusted Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) Is Active and Well-Tolerated in Adults with Newly-Diagnosed Acute Lymphoblastic Leukemia/Lymphoma (ALL): Initial Results of a Phase II Trial
Sign Up to like & getrecommendations! Published in 2018 at "Blood"
DOI: 10.1182/blood-2018-99-110661
Abstract: BACKGROUND: HyperCVAD is used commonly in adult ALL but can be difficult for older or infirm patients (pts) to tolerate (JCO 2000, p. 547; Cancer 2008, p. 2097). At our center, only 50% who receive… read more here.
Keywords: cycle; mfc; epoch; research funding ... See more keywords
DA-EPOCH Was Not Better Than CHOP for Acquired Immunodeficiency Syndrome-Related Diffuse Large B Cell Lymphoma Patients Treated in a South Brazilian University Hospital
Sign Up to like & getrecommendations! Published in 2018 at "Blood"
DOI: 10.1182/blood-2018-99-117862
Abstract: Introduction: Lymphomas are an important complication of HIV infection where they occur with high frequency and are a significant cause of morbidity and mortality.The most prevalent lymphoma subtype in HIV positive population is the diffuse… read more here.
Keywords: dlbcl; patients treated; treatment; hiv ... See more keywords
A Randomized Trial of EPOCH-Based Chemotherapy with Vorinostat for Highly Aggressive HIV-Associated Lymphomas: Updated Results Evaluating Impact of Diagnosis-to-Treatment Interval (DTI) and Pre-Protocol Systemic Therapy on Outcomes
Sign Up to like & getrecommendations! Published in 2019 at "Blood"
DOI: 10.1182/blood-2019-129687
Abstract: Introduction: EPOCH-based chemotherapy is considered a preferred first-line treatment for HIV-associated diffuse large B-cell lymphoma (DLBCL) and primary effusion lymphoma in the 2019 NCCN guidelines. We previously reported that adding the HDAC inhibitor vorinostat (VOR)… read more here.
Keywords: chemotherapy; treatment; hiv; pre ... See more keywords
Comparing CHOP, R-CHOP, R-EPOCH, and DA-EPOCH-R in HIV-associated diffuse large B-cell lymphoma: A meta-analysis and systematic review
Sign Up to like & getrecommendations! Published in 2025 at "Blood"
DOI: 10.1182/blood-2025-5469
Abstract: INTRODUCTION Diffuse Large B-Cell lymphoma (DLBCL) is the most common subtype of non-hodgkin lymphoma in patients with human immunodeficiency virus (HIV) infection. These patients typically have a worse outcome due to more aggressive histology and… read more here.
Keywords: chop; chop chop; hiv positive; analysis ... See more keywords
Transition of dose-adjusted EPOCH therapy into the outpatient healthcare setting: Quality and cost considerations for outpatient treatment.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.30_suppl.110
Abstract: 110 Background: Dose-adjusted etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin (EPOCH)-containing regimens are frequently utilized in lymphoma, however, outpatient EPOCH or modified inpatient/outpatient EPOCH has not been described extensively. We transitioned inpatient EPOCH to the outpatient setting… read more here.
Keywords: quality; dose adjusted; outpatient setting; outpatient ... See more keywords